News archive
2010
2009
2008
Older
Last patient out for Paccal® Vet Phase III study
2010-03-01
Interim report May 1, 2009 - January 31, 2010
2010-02-26
Oasmia changes report publication date
2009-12-28
2009
Oasmia publishes Interim Report for May - Oct
2009-12-10
Oasmia starts clinical studies with Doxophos® Vet
2009-12-09
Oasmia carries out private placement
2009-11-05
Oasmia successfully concludes enrolment
2009-10-21
Communiqué from Annual General Meeting
2009-09-28
Interim report May 1 - July 31 2009
2009-09-10
Oasmia’s rights issue fully subscribed
2009-08-28
Notice of Annual General Meeting 2009
2009-08-27
Oasmia SA’s commitment in rights issue
2009-08-25
Oasmia announces distribution agreement
2009-07-13
Oasmia publishes prospectus
2009-08-03
Oasmia announces license agreement with Abbott
2009-07-10
Oasmia proposes new share issue
2009-06-24
Prize to Oasmia
The 29th of April Oasmia received a award in Stockholm
FDA grants Paclical® Orphan Drug Designation
2009-04-14
Oasmia: FDA grants Paccal Vet Minor Use status
2009-04-01
Interim Report May 2008 - January 2009
2009-03-19
Phase III study generates great interest in Europe
2009-02-11
Oasmia aims for global registration of Paccal Vet
2009-02-05
Communiqué from Extraordinary General Meeting
2009-02-02
Promising clinical results for Paclical
2009-01-27
Solid scientific evidence for Paccal Vet
2009-01-21
FDA grants Expedited Review Status to Paclical Vet
2009-01-14
Call to Extraordinary Genral Meeting
2009-01-12
2008
Oasmia appoints market maker
2008-12-01
Oasmia changes marketplace
2008-10-01
Notice of Annual General Meeting
2008-08-14
Oasmia expands license agreement for Paclical Vet
2008-06-25
New license agreement with Orion Corporation
2008-03-26
Phase III results presented in Copenhagen
2008-03-03
Oasmia presents Phase III-results in Denmark
2008-01-31
Final advice for Paclical Phase III program
2008-01-29
Older
Oasmia announces licensing agreement
2007-11-27
Oasmia presented in Florida
2007-11-05
Oasmia presents in USA
2007-10-09
Oasmia in Barcelona
2007-09-27
Great interest for Oasmia in Budapest
2007-09-20
Oasmia to NGM Equity
2007-09-17
Oasmia publishes Listing Prospectus
2007-09-17
Oasmia presents in Budapest
2007-06-19
“Jackpot in sight for Oasmia”
2007-06-07
Status – listing of Oasmia
2007-05-29
Very good clinical results for Paclical®
2007-04-16
Unique results for cancer drug
2007-03-27
New drug for treatment of cancer in dog
2007-03-13
OASMIA confirms Orphan Drug Designation
2006-11-30
Oasmia obtains Orphan Drug designation
2006-11-15